ANTISERA CAPI 3 IT (10) 2601

GUDID 03607360026014

SEBIA

Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent Multiple clinical chemistry protein IVD, reagent
Primary Device ID03607360026014
NIH Device Record Keycd178ff2-5269-422f-97af-1d519925048d
Commercial Distribution StatusIn Commercial Distribution
Brand NameANTISERA CAPI 3 IT (10)
Version Model Number2601
Catalog Number2601
Company DUNS276801933
Company NameSEBIA
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usefalse
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *This way up Do not freeze Fragile handle with care Keep dry

Device Identifiers

Device Issuing AgencyDevice ID
GS103607360026014 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

CFFImmunoelectrophoretic, Immunoglobulins, (G, A, M)

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2023-12-07
Device Publish Date2023-11-29

Devices Manufactured by SEBIA

03607360026014 - ANTISERA CAPI 3 IT (10)2023-12-07
03607360026014 - ANTISERA CAPI 3 IT (10)2023-12-07
03607360026021 - Sample Diluent CAPI 3 IT (10)2023-12-07
03607360020098 - CAPILLARYS CDT2023-09-13 CARBOHYDRATE DEF TRANSFERRING BY CE
03607360020296 - CAPILLARYS CDT MAXI KIT2023-09-13 CARBOHYDRATE DEF TRANSFERRIN BY CE MAXI KIT
03607360022085 - MINICAP CDT2023-09-13 CARBOHYDRATE DEF TRANSFERRIN BY MINICAP CE
03607360022283 - MINICAP CDT MAXI KIT2023-09-13 CARBOHYDRATE DEF TRANSFERRIN BY CE MINICAP
03607360025093 - CAPI 3 CDT2023-09-13 CARBOHYDRATE DEF TRANSFERRIN BY CE
03607360047583 - Hb AFSA2 CONTROL (1)2023-08-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.